Nina Copeland
Family · Fort Smith, ARNPI 1295093532
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $179,792 of the $207,464 with a category attached, or 86.7%. AbbVie accounts for 95.7% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $98,432 and has fallen 97.5% since, to $2,421 in 2025. Among family clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 744 payments — averaging $278.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$199K
- Novartis$901
- Galderma Laboratories, L.p.$800
- Johnson & Johnson$759
- Lilly USA, LLC$748
- Sanofi$708
- plus $5K from 21 others
What the payments were for
- Consulting fees$5000%
- Speaking & faculty fees$179,79287%
- Travel & lodging$14,0357%
- Food & beverage$12,9236%
- Education$2140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 286 | $198,515 |
| Novartis | 49 | $901 |
| Galderma Laboratories, L.p. | 77 | $800 |
| Johnson & Johnson | 45 | $759 |
| Lilly USA, LLC | 38 | $748 |
| Sanofi | 22 | $708 |
| Dermavant Sciences, Inc. | 21 | $600 |
| Regeneron Healthcare Solutions, Inc. | 26 | $531 |
| Sun Pharmaceutical Industries Inc. | 23 | $503 |
| Amgen | 20 | $492 |
| Arcutis Biotherapeutics, Inc. | 9 | $428 |
| Revance Therapeutics, Inc. | 6 | $377 |
| LEO Pharma Inc. | 23 | $357 |
| E.r. Squibb & Sons, L.L.C. | 17 | $337 |
| UCB, Inc. | 20 | $303 |
| Incyte Corporation | 18 | $302 |
| Pfizer | 14 | $199 |
| Mayne Pharma Commercial LLC | 9 | $155 |
| VYNE Pharmaceuticals Inc. | 3 | $130 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $93 |
| Kerecis Limited | 2 | $41 |
| Genentech USA, Inc. | 2 | $40 |
| Kyowa Kirin, Inc. | 2 | $33 |
| Biofrontera Inc. | 2 | $33 |
| Organon | 2 | $32 |
| Almirall LLC | 2 | $31 |
| Sandoz | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$207,464 in reported general payments places this provider in the 95th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 17 | $222 |
| ValacyclovirValacyclovir Hcl | 22 | $141 |
Paid to pharmacies, not to this prescriber.
Other family in Fort Smith
- Amanda DavisFort Smith$46K
- Scarlett BoneFort Smith$16K
- Nathan WilliamsonFort Smith$15K
- Yong OunpraseuthFort Smith$14K
- Karen WilliamsFort Smith$11K
- Nycole OliverFort Smith$10K
- Bentlee RundellFort Smith$10K
- Nata MatthewsFort Smith$10K
- Emily ChristensenFort Smith$9K
- Karen ThriftFort Smith$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.